Asia Pacific PCR for Respiratory Infection Diagnostics Market
Polymerase chain reaction (PCR) is used for accurate point of care diagnostics that help rapidly identify and determine the cause of respiratory tract infections. In addition, PCR is widely preferred in inpatient and outpatient settings that help enhance the growth of the market in recent years.
Strategic insights for the Asia Pacific PCR for Respiratory Infection Diagnostics provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 737.47 Million |
| Market Size by 2028 | US$ 1,515.94 Million |
| Global CAGR (2021 - 2028) | 10.8% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | Asia-Pacific
|
| Market leaders and key company profiles |
The geographic scope of the Asia Pacific PCR for Respiratory Infection Diagnostics refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Asia Pacific PCR for respiratory infection diagnostics market is expected to reach US$ 1,515.94 million by 2028 from US$ 737.47 million in 2021; it is estimated to grow at a CAGR of 10.8% from 2021 to 2028. The growth of the market is attributed to some of the key driving factors such as increasing developments in PCR technology and rising use of PCR testing for various respiratory infection diagnostics. However, availability of alternative assays is the major factor hindering the market growth.
PCR has become an indispensable tool for various clinical and diagnostic applications or examinations due to continuous research & development on PCR technologies. Therefore, it offers many opportunities for rapid point-of-care diagnostics for various infectious diseases. For instance, F. Hoffmann-La Roche Ltd is continuously working on the advancements of dPCR techniques. Digital PCR (dPCR) has extended its applications to the clinical field and has emerged as an important clinical tool. dPCR offers ultrasensitive and absolute nucleic acid quantification without reference standard. Thus, it offers a broader aspect for standardizing and comparing results between laboratories. In addition, rising incidence of target infectious diseases and genetic disorders; increasing investments, funds, and grants; and growing utilization of biomarker profiling for disease diagnostics are among other factors that are likely to make PCR an indispensable tool for the future. In addition, PCR testing is significantly used in institutions such as nursing homes, chronic care facilities, and hospitals for identifying influenza virus infection that causes respiratory outbreaks. Therefore, various companies are offering PCR kits that can detect the presence of pathogens causing respiratory diseases. Apart from the increasing incidence of acute and chronic respiratory diseases, other factors such as environmental and climatic conditions, air pollution, and discoveries of novel bacteria, viruses, and pathogens are likely to serve as vital growth opportunities for PCR testing for respiratory infection diagnostics in the coming future.
COVID-19 pandemic has widely affected the economies in the Asia Pacific region. The rising occurrence COVID-19 cases results in increased stress on the region's healthcare system, which is also rising the demand for diagnostic tests in the healthcare system, supporting the expansion of the sector in this region. Hence, countries such as India, China, and South Korea have increased their capacities to conduct PCR testing. Several manufacturers are developing advanced PCR test kits and systems for the detection of COVID-19 virus. Also, high throughput molecular testing is expected to play a central role in the future management of the COVID-19 pandemic. Thus, such developments in the market are likely to foster the growth of market during the forecast period.
Based on type, the Asia Pacific PCR for respiratory infection diagnostics market is segmented into real time PCR (qPCR), traditional PCR, reverse-transcriptase (RT-PCR), digital PCR, multiplex PCR, and others. The real-time PCR (qPCR) segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.
Based on product type, the Asia Pacific PCR for respiratory infection diagnostics market is segmented into reagents and kits, instruments, and others. The reagents and kits segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.
Based on infection type, the Asia Pacific PCR for respiratory infection diagnostics market is segmented into bacterial infection, viral infection, and fungal and other pathogens. In 2021, viral infections segment held the largest share of the market and is estimated to register the highest CAGR in the market during the forecast period.
Based on end user, the Asia Pacific PCR for respiratory infection diagnostics market is segmented into hospitals, physician clinics, clinical laboratories, academic and research institutions, biotech and pharma companies, and others. In 2020, clinical laboratories segment held the largest share of the market and is estimated to register the highest CAGR in the market during the forecast period.
A few of the primary and secondary sources associated with this report on the Asia Pacific PCR for respiratory infection diagnostics market are Global Burden of Diseases (GBD), Australian Lung Foundation (ALF) and the National Library of Medicine.
The Asia Pacific PCR for Respiratory Infection Diagnostics Market is valued at US$ 737.47 Million in 2021, it is projected to reach US$ 1,515.94 Million by 2028.
As per our report Asia Pacific PCR for Respiratory Infection Diagnostics Market, the market size is valued at US$ 737.47 Million in 2021, projecting it to reach US$ 1,515.94 Million by 2028. This translates to a CAGR of approximately 10.8% during the forecast period.
The Asia Pacific PCR for Respiratory Infection Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific PCR for Respiratory Infection Diagnostics Market report:
The Asia Pacific PCR for Respiratory Infection Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific PCR for Respiratory Infection Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific PCR for Respiratory Infection Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific PCR for Respiratory Infection Diagnostics Market
